Carrying of HBsAg and the Effect o Levarnisole on HBsAg Carriers

HALUK YAVUZ, DURSUN ODABAŞ, ÜMRAN ÇALIŞKAN, Kenan Haspolat

  • Year : 1989
  • Vol : 5
  • No : 3
  •  Page : 110-112
We have investigağed the incid.ence of chronic carrying of HBsAg in patients with hepatitis and the effect of levamisole in these patients. HEsAg pozitivity in 18 of 175 patients continued for 3 years. 12 of these 18 patients were giyen levamisole as 2.5 mgikg three days in a week for two moriths. At the end of this period HBsAg was disappeared in 8 of ther/L There was no change in 6 control cases who were giyen placebo at the end of the sarne period.
Cite this Article As :
Description : None of the authors, any product mentioned in this article, does not have a material interest in the device or drug. Research, not supported by any external organization. grant full access to the primary data and, if requested by the magazine they agree to allow the examination of data.
Carrying of HBsAg and the Effect o Levarnisole on HBsAg Carriers
, Vol. 5 (3)
Received : 20.11.1989, Accepted : 20.11.1989, Published Online : 20.11.2020
Selçuk Tıp Dergisi
ISSN:1017-6616;
E-ISSN:2149-8059;
  • article icon Araştırma Makalesi
  • pdf icon View as PDF
  •   keyword icon Keywords Carrying of HBsAg and the Effect o Levarnisole on HBsAg Carriers